Table 3: Main Predictive Factors for Post-discharge Mortality Derived from EVEREST Trial Sub-analyses.
Baseline | Discharge | 1 week | |
---|---|---|---|
Systolic blood pressure | + | + | + |
Heart rate | No | No | + |
Congestion score | - | + | + |
B-type natriuretic peptide | - | + | + |
Large QRS duration | + | - | - |
Low cholesterol | + | - | - |
Hepatic function test:
|
No + + |
No + + |
- - - |
Haematocrit | - | + | - |
Low osmolality | - | + | - |
Hyponatraemia | + | - | - |
Potassium | No | No | - |
High seric uric acid* | + | ||
Anaemia | No | + | - |
*Only in patients with normal baseline renal function. + = predictive value; - = no information; ALT = alanine aminotransferase; AST = aspartate aminotransferase.